Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
APVO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.33M
- P/E (TTM)
- 0.03
- EPS (TTM)
- $66.96
- Dividend yield
- None
- 52-week range
- 1.37 – 33.12
- Day range
- 1.76 – 1.85
- Volume / Avg
- 12.01K / 94.92K
- Beta
- —
- Shares outstanding
- 1.81M
- Next earnings
- Nov 5, 2026
52-week range
APVO stock today
Aptevo Therapeutics (APVO) closed at $1.84 on Oct 7, up 2.51% (+$0.045), versus the S&P 500's 0.22% decline. Trading was light, with 12.01K shares changing hands, about 13% of the average daily volume. At this level, APVO sits near the bottom of its 52-week range of $1.37 to $33.12: 94.4% below the high and 34.3% above the low.
Aptevo Therapeutics trades at 0.0x its trailing twelve-month earnings per share of $66.96. Aptevo Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Aptevo Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Seattle, WA
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-3.72
APVO news
All APVO newsAptevo Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CMNDClearmind Medicine Inc. | 6.60 | +13.01% | $3.35M | vs APVO |
| REVBRevelation Biosciences Inc. | 0.8281 | +10.12% | $3.30M | vs APVO |
| MBIOMustang Bio Inc. | 0.4502 | -2.13% | $3.41M | vs APVO |
| CVKDCadrenal Therapeutics Inc. | 0.9723 | -1.79% | $3.47M | vs APVO |
| HCWBHCW Biologics Inc. | 1.56 | -0.64% | $3.49M | vs APVO |
| XRTXXORTX Therapeutics Inc. | 1.75 | +0.87% | $3.17M | vs APVO |
| PRFXPRF Technologies Ltd. | 0.8777 | -0.27% | $3.07M | vs APVO |
| SBFMSunshine Biopharma Inc. | 0.70 | +75.92% | $3.02M | vs APVO |
Indexes, lists and sector
Aptevo Therapeutics stock FAQ
What is Aptevo Therapeutics's stock price today?
APVO last traded at $1.84 as of Oct 7, 4:00 PM EDT, up 2.51% on the day. Prices are delayed at least 15 minutes.
When is Aptevo Therapeutics's next earnings date?
Aptevo Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-3.72.
What is APVO's P/E ratio?
APVO trades at a trailing P/E ratio of 0.03.
What is the APVO 52-week high?
The 52-week high for APVO is $33.12 and the 52-week low is $1.37. The stock is currently 94.4% below its high.